Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,414 shares at $109.95 ($265K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Seasonal sale ($265k) by Chief Commercial Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $109.95 | 1,207 | $133K | 50.0% |
| 2 | $109.95 | 1,207 | $133K | 50.0% |
| Total | $109.95 avg | 2,414 | $265K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |